908 Devices Inc. (MASS)

USD 1.88

(-7.39%)

Market Cap (In USD)

65.46 Million

Revenue (In USD)

50.22 Million

Net Income (In USD)

-36.39 Million

Avg. Volume

208.22 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.825-12.51
PE
-
EPS
-
Beta Value
0.976
ISIN
US65443P1021
CUSIP
65443P102
CIK
1555279
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Kevin J. Knopp Ph.D.
Employee Count
-
Website
https://www.908devices.com
Ipo Date
2020-12-18
Details
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.